News
The nuclear pore complex protein RANBP2 has emerged as a critical factor in the development and progression of various solid malignancies.
A Weymouth family known for their son's cancer battle faces heartbreak again as dad Jarlath Waters is diagnosed with glioblastoma.
A series of preclinical studies show that a new compound, SHP1705, targets circadian clock proteins hijacked by glioblastoma ...
Researchers developed a biomimetic nanovesicle that crosses the blood-brain barrier, degrades DNA repair proteins, and ...
Two research articles published in Nature Genetics shed new light on the cellular complexity of glioblastoma, the most ...
Brain tumors strike over 25,000 Americans annually with often subtle warning signs. Learn crucial facts about detection, ...
Hundreds of people braved the chilly rain on Saturday morning to take part in the Georgia Brain Tumor Walk and Race to raise ...
Dr. Bobby Mukkamala, a popular Flint doctor, said he had a one percent chance of dying after a cancer diagnosis in the fall.
The wet weather on Sunday morning didn't stop thousands of people from coming out to raise awareness for brain cancer, which ...
4d
Pharmaceutical Technology on MSNViralgen and Trogenix to progress gene therapy for glioblastomaThe partnership has enabled Viralgen to scale up and complete a GMP trial material batch of Trogenix's therapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results